![PRD_001210 PRD_001210](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/ALD.svg) | PRD_001210 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide | Formula: | C26 H43 N3 O5 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
![PRD_001166 PRD_001166](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001166.svg) | PRD_001166 | Name: | bicyclic peptide UK749 | Formula: | C71 H108 N25 O20 S3 | Definition date: | 2014-02-05 | Last modified: | 2014-02-05 |
|
![PRD_001167 PRD_001167](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001167.svg) | PRD_001167 | Name: | bicyclic peptide UK811 | Formula: | C74 H119 N26 O22 S3 | Definition date: | 2014-02-05 | Last modified: | 2014-02-05 |
|
![PRD_001168 PRD_001168](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001168.svg) | PRD_001168 | Name: | bicyclic peptide UK903 | Formula: | C72 H103 N19 O19 S3 | Definition date: | 2014-02-05 | Last modified: | 2014-02-05 |
|
![PRD_000902 PRD_000902](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/ONK.svg) | PRD_000902 | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C27 H50 N4 O5 | Description: | vinylketone carmaphycin analogue VNK1, single bound form | Definition date: | 2014-01-29 | Last modified: | 2017-05-04 |
|
![PRD_000904 PRD_000904](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/VNK.svg) | PRD_000904 | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C27 H52 N4 O5 | Description: | vinylketone carmaphycin analogue VNK1, double bound form | Definition date: | 2014-01-29 | Last modified: | 2017-05-04 |
|
![PRD_000930 PRD_000930](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/OV2.svg) | PRD_000930 | Name: | N-hexanoyl-L-valyl-N~1~-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C27 H52 N4 O6 | Description: | epoxyketone carmaphycin analogue 3, bound form | Definition date: | 2014-01-29 | Last modified: | 2023-11-03 |
|
![PRD_000956 PRD_000956](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/OV1.svg) | PRD_000956 | Name: | N-[(2S)-1-({(2S)-1-{[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]amino}-4-[(R)-methylsulfinyl]-1-oxobutan-2-yl}amino)-3-methyl-1-oxobutan-2-yl]hexanamide | Formula: | C25 H49 N3 O6 S | Description: | Carmaphycin A, bound form | Definition date: | 2014-01-29 | Last modified: | 2023-11-03 |
|
![PRD_001157 PRD_001157](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001157.svg) | PRD_001157 | Name: | Ser-Leu-Phe-His-Phenylalanyl-reduced-peptide-bond-Tyrosyl-Thr-Pro | Formula: | C51 H69 N10 O11 | Definition date: | 2014-01-15 | Last modified: | 2023-11-03 |
|
![PRD_001211 PRD_001211](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001211.svg) | PRD_001211 | Name: | LEDGF peptide | Formula: | C27 H45 N8 O9 | Definition date: | 2013-12-25 | Last modified: | 2014-03-25 |
|
![PRD_001212 PRD_001212](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001212.svg) | PRD_001212 | Name: | LEDGF peptide | Formula: | C28 H48 N9 O10 S2 | Definition date: | 2013-12-25 | Last modified: | 2013-12-25 |
|
![PRD_001213 PRD_001213](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001213.svg) | PRD_001213 | Name: | PK(NLE)DN(DVA) peptide | Formula: | C30 H51 N8 O9 | Definition date: | 2013-12-25 | Last modified: | 2013-12-25 |
|
![PRD_001214 PRD_001214](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001214.svg) | PRD_001214 | Name: | PKIDN(DPR) peptide | Formula: | C30 H49 N8 O9 | Definition date: | 2013-12-25 | Last modified: | 2013-12-25 |
|
![PRD_001156 PRD_001156](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001156.svg) | PRD_001156 | Name: | PL-55 | Formula: | C41 H67 N9 O12 P S | Definition date: | 2013-12-11 | Last modified: | 2013-12-11 |
|
![PRD_001159 PRD_001159](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001159.svg) | PRD_001159 | Name: | PL-74 | Formula: | C46 H74 N10 O13 P S | Definition date: | 2013-12-11 | Last modified: | 2013-12-11 |
|
![PRD_001125 PRD_001125](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001125.svg) | PRD_001125 | Name: | Peptide ligand | Formula: | C51 H75 N9 O14 | Definition date: | 2013-12-04 | Last modified: | 2023-11-03 |
|
![PRD_002043 PRD_002043](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_002043.svg) | PRD_002043 | Name: | Goblin1 | Formula: | C34 H60 N8 O12 | Definition date: | 2013-12-04 | Last modified: | 2022-10-29 |
|
![PRD_001189 PRD_001189](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001189.svg) | PRD_001189 | Name: | ATSP-7041 stapled-peptide | Formula: | C87 H124 N16 O22 | Definition date: | 2013-11-20 | Last modified: | 2023-11-03 |
|
![PRD_001130 PRD_001130](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001130.svg) | PRD_001130 | Name: | SmBz, cyclosporin A derivative | Formula: | C70 H118 N11 O14 | Definition date: | 2013-11-06 | Last modified: | 2013-11-06 |
|
![PRD_001186 PRD_001186](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001186.svg) | PRD_001186 | Name: | Myosin-A, stapled peptide | Formula: | C97 H175 N31 O23 S | Description: | SYNTHESISED PEPTIDE MIMIC OF PLASMODIUM FALCIPARUM MYOSIN A TAIL | Definition date: | 2013-11-06 | Last modified: | 2017-12-15 |
|
![PRD_001187 PRD_001187](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001187.svg) | PRD_001187 | Name: | pGly[807,811], a stapled myoA tail peptide | Formula: | C98 H177 N31 O23 S | Definition date: | 2013-11-06 | Last modified: | 2013-11-06 |
|
![PRD_001188 PRD_001188](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001188.svg) | PRD_001188 | Name: | hydrogen bond surrogate (HBS) myoA helix mimetic | Formula: | C92 H167 N29 O22 S | Definition date: | 2013-11-06 | Last modified: | 2013-11-06 |
|
![PRD_001173 PRD_001173](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001173.svg) | PRD_001173 | Name: | Phosphothreonine ester-containing peptide | Formula: | C44 H72 N8 O13 P | Definition date: | 2013-10-30 | Last modified: | 2014-01-23 |
|
![PRD_000777 PRD_000777](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000777.svg) | PRD_000777 | Name: | N-[(2S)-2-({N~5~-[(1E)-ethanimidoyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucine | Formula: | C41 H69 N9 O9 | Definition date: | 2013-10-30 | Last modified: | 2013-10-30 |
|
![PRD_000778 PRD_000778](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000778.svg) | PRD_000778 | Name: | N-[(2S)-2-({N~5~-[(1E)-ethanimidoyl]-L-ornithyl-L-valyl}amino)-3-phenylpropyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucine | Formula: | C44 H67 N9 O9 | Definition date: | 2013-10-30 | Last modified: | 2013-10-30 |
|